Praxis Precision Medicines, Inc. reported earnings results for the fourth quarter ended December 31, 2022. For the fourth quarter, the company reported net loss was USD 41.17 million compared to USD 58.58 million a year ago. Basic loss per share from continuing operations was USD 0.87 compared to USD 1.3 a year ago.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
47.23 USD | +4.93% | +2.94% | +112.07% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+112.07% | 770M | |
+41.14% | 54.04B | |
+43.57% | 41.96B | |
-1.23% | 41.92B | |
-7.59% | 28.35B | |
+12.42% | 26.35B | |
-22.19% | 19B | |
+7.71% | 13B | |
+28.68% | 12.28B | |
+24.76% | 12.19B |
- Stock Market
- Equities
- PRAX Stock
- News Praxis Precision Medicines, Inc.
- Praxis Precision Medicines, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022